Skip to content

Alinity 08P4930Recalls & reported problems

Abbott GmbH · Alinity i CA 125 II Reagent Kit 1000 Tests · Class 2

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00380740131050), received between Apr 24, 2024 and Mar 20, 2026 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “High Test Results” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 1 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • High Test Results1
  • Low Test Results1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 20, 2026Low Test Results

    THE CUSTOMER OBSERVED A FALSE DEPRESSED ALINITY I CA 125 II RESULT FOR A 70-YEAR-OLD FEMALE PATIENT THAT HAS BEEN DIAGNOSED WITH OVARIAN CANCER. THE FOLLOWING RESULTS WERE PROVIDED: (LAB REFERENCE RANGE FOR CA125 <35 KU/L) (B)(6) 2026, SID (B)(6) INITIAL RESULT = 10 KU/L, (B)(6) 2026 REPEAT RESULT = 899 KU/L, RESULT AFTER 1:10 DILUTION = 1008 KU/L . NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24647581 ↗
  • InjuryApr 24, 2024High Test Results; High Test Results

    UPDATE: ADDITIONAL CLARIFYING INFORMATION WAS RECEIVED FROM THE CUSTOMER: THE ADDITIONAL TESTING AND SCANS WERE COMPLETED AFTER THE INITIAL RESULTS FROM (B)(6) 2024 WERE REPORTED. (B)(6) 2024: CERVICAL SMEAR FOR CYTOLOGY. (B)(6) 2024: G&C SCOPE. (B)(6) 2024: ENDOMETRIAL BIOPSY. THE DATES OF THE OTHER TESTING/SCANS ARE UNKNOWN. THE DETAILS OF THE FAMILY HISTORY OF CANCER IS UNKNOWN. NO FURTHER IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19176985 ↗

Other TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125) devices

All TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125) devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.